Latest Commercialization News

PainChek Limited has confirmed FDA De Novo classification for its PainChek Adult App, promptly disclosing the material regulatory milestone to the ASX and signalling a significant step towards US market entry.

Health Canada has requested additional information, extending its review of CLINUVEL’s SCENESSE® for erythropoietic protoporphyria (EPP) into 2026. Meanwhile, Canadian patients continue to access the treatment via a Special Access Program.

Aspen Group has upgraded its FY26 pre-tax earnings guidance by 6%, driven by strong rental income growth and development profits amid Australia's acute housing shortage. The company also announces a strategic acquisition of a new Sydney headquarters.

Connexion Mobility reported a modest 1% revenue increase to $2.9 million in Q1 FY26, while net profit before tax declined 19% due to the absence of prior quarter government incentives. The company is advancing its SaaS platform footprint in US automotive retail and investing strategically in Covertrue Group.

PolyNovo Limited has appointed Bruce Peatey as its new CEO, bringing extensive international healthcare experience to drive the company’s next growth phase. Peatey’s leadership is expected to accelerate PolyNovo’s expansion into new markets and outpatient care.

Firebrick Pharma has secured a $102,000 investment from its Philippines strategic partner, Pharma Nutria N.A., Inc., reinforcing its position ahead of the Nasodine nasal spray launch in 2026.

G50 Corp’s latest quarterly report reveals a significant new precious metals discovery at its Golconda Project alongside promising antimony results at White Caps, supported by a $10 million capital raise to advance exploration.

Anteris Technologies has secured its first European regulatory clearance to commence the global PARADIGM Trial for its DurAVR Transcatheter Heart Valve, marking a significant step toward worldwide commercialization.

Qualitas Real Estate Income Fund (QRI) has announced a $162 million non-renounceable entitlement offer at $1.60 per unit, aiming to capitalize on a robust pipeline of commercial real estate loans. The offer provides existing investors an opportunity to deepen exposure to Australia's evolving private credit market.

Carnaby Resources has completed the acquisition of the remaining 17.5% stake in the Greater Duchess Copper Gold Joint Venture, gaining 100% ownership and full operational control. This strategic move positions Carnaby to accelerate development and unlock the project’s significant copper-gold potential.

Jade Gas Holdings has raised A$5 million through a placement to advance commercial gas production at its Red Lake field, with a follow-up Share Purchase Plan aiming to raise an additional A$2.1 million.

Clarity Pharmaceuticals has inked a pivotal supply agreement with Nusano to ensure a steady source of copper-67, a critical isotope for its upcoming Phase III prostate cancer trial and future commercialisation plans.